Study on the Expression and Potential Function of LncRNA in Peripheral Blood of Patients with Ankylosing Spondylitis

Page: [544 - 554] Pages: 11

  • * (Excluding Mailing and Handling)

Abstract

Background: Ankylosing spondylitis (AS) is an autoimmune disease that has the characteristics of difficult early diagnosis and a high disability rate.

Objective: The objective of this study was to further explore the possible mechanism and potential function of lncRNA in AS.

Methods: We used lncRNA microarray technology to detect the expression of lncRNA and mRNA in patients with active AS, stable patients, and healthy controls (HC). Afterward, bioinformatics analysis was conducted on differentially expressed genes. Seven differentially expressed lncRNAs were screened out for real-time fluorescent quantitative PCR (RT-qPCR), combined with various clinical indicators for correlation analysis, and the receiver operating characteristic (ROC) curve was used to analyze the potential of lncRNA as a diagnostic marker for AS.

Results: The results showed that the expression levels of NR-037662 and ENST00000599316 in the AS subgroups were significantly higher than those in the HC group, while the expression levels of ENST00000577914 and ENST00000579003 were lower than those in the HC group. The expression levels of NR-003542 and ENST00000512051 in the ASA group were significantly higher than those in the ASS and HC groups, while NR-026756 was just the opposite. Spearman’s correlation analysis showed that the expression level of NR-003542 was positively correlated with Bath Ankylosing Spondylitis Functional Index (BASFI), Erythrocyte Sedimentation Rate (ESR), and high sensitivity C-Reactive Protein (hsCRP). The expression level of NR-026756 was negatively correlated with the Bath Ankylosing Spine Inflammatory Disease Activity Index (BASDAI), BASFI, ESR, hsCRP, and globulin (GLOB). In addition, it was also found that the ROC curve analysis of the 4 lncRNAs between the AS group (ASA group and ASS group) and the HC group were statistically significant, and the area under the curve (AUC) of NR-037662, ENST00000599316, ENST00000577914, and ENST00000579003 was 0.804, 0.812, 0.706, and 0.698, respectively.

Conclusion: It was found that these differentially expressed lncRNAs of AS may be involved in the occurrence and development of the disease. Among them, NR-037662, ENST00000599316, ENST00000577914, and ENST00000579003 might have the potential to become AS diagnostic molecular markers. Moreover, NR -003542, ENST00000512051, and NR-026756 might have the potential to be indicators of disease activity.

Graphical Abstract

[1]
Bohn R, Cooney M, Deodhar A, Curtis J, Golembesky AJC. Incidence and prevalence of axial spondyloarthritis: methodologic challenges and gaps in the literature. Clin Exp Rheumatol 2018; 36(2): 263-74.
[2]
Zhao S, Pittam B, Harrison N, Ahmed A, Goodson N, Hughes DJR. Diagnostic delay in axial spondyloarthritis: A systematic review and meta-analysis. Rheumatology 2021; 60(4): 1620-8.
[http://dx.doi.org/10.1093/rheumatology/keaa807]
[3]
Zhu W, He X, Cheng K, et al. Ankylosing spondylitis: Etiology, pathogenesis, and treatments. Bone Res 2019; 7: 22.
[http://dx.doi.org/10.1038/s41413-019-0057-8]
[4]
Rinn JL, Chang HY. Long noncoding RNAs. Molecular modalities to organismal functions. Annual Review of Biochem 2020; 89: 283-308.
[http://dx.doi.org/10.1146/annurev-biochem-062917-012708] [PMID: 32569523]
[5]
Statello L, Guo C, Chen L. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 2021; 22: 96-118.
[http://dx.doi.org/10.1038/s41580-020-00315-9]
[6]
Goodall G, Wickramasinghe VJNrC. RNA in cancer. Nat Rev Cancer 2021; 21(1): 22-36.
[http://dx.doi.org/10.1038/s41568-020-00306-0]
[7]
Greenhill C. Role of long non-coding RNA in T1DM Nat Rev Endocrinol 2020; 16: 344-5.
[http://dx.doi.org/10.1038/s41574-020-0368-2]
[8]
Gomes CPC, Schroen B, Kuster GM, et al. Regulatory RNAs in heart failure. Circulation 2020; 141(4): 313-28.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042474] [PMID: 31986093]
[9]
Lüscher TF. Novel molecular mechanisms of vascular disease: Non-coding RNAs, inflammation, and radiation. Eur Heart J 2019; 40(30): 2467-70.
[http://dx.doi.org/10.1093/eurheartj/ehz541]
[10]
Xu Z, Zhou X, Li H, Chen Q, Chen G. Identification of the key genes and long non-coding RNAs in ankylosing spondylitis using RNA sequencing. Int J Mol Med 2019; 43(3): 1179-92.
[http://dx.doi.org/10.3892/ijmm.2018.4038]
[11]
Sieper J, Poddubnyy DJL. Axial spondyloarthritis. Lancet 2017; 390(10089): 73-84.
[http://dx.doi.org/10.1016/S0140-6736(16)31591-4]
[12]
Costantino F, Talpin A, Said-Nahal R, et al. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis 2015; 74(4): 689-93.
[http://dx.doi.org/10.1136/annrheumdis-2013-204436]
[13]
Chan V, Chan P, Chiu K, Yan C, Ng FY. Why do Hong Kong patients need total hip arthroplasty? An analysis of 512 hips from 1998 to 2010. Hong Kong Med J 2016; 22(1): 11-5.
[http://dx.doi.org/10.12809/hkmj144483]
[14]
Sarropoulos I, Marin R, Cardoso-Moreira M, Kaessmann HJN. Developmental dynamics of lncRNAs across mammalian organs and species. Nature 2019; 571(7766): 510-4.
[http://dx.doi.org/10.1038/s41586-019-1341-x]
[15]
Gil N, Ulitsky I. Regulation of gene expression by cis-acting long non-coding RNAs. Nat Rev Genet 2020; 21(2): 102-17.
[http://dx.doi.org/10.1038/s41576-019-0184-5]
[16]
Anandagoda N, Willis J, Hertweck A, et al. MicroRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest 2019; 129(3): 1257-71.
[http://dx.doi.org/10.1172/JCI124725]
[17]
Ding S, Liang Y, Zhao M, et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum 2012; 64(9): 2953-63.
[http://dx.doi.org/10.1002/art.34505]
[18]
Talebi F, Ghorbani S, Chan W, et al. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. J Neuroinflammation 2017; 14(1): 55.
[http://dx.doi.org/10.1186/s12974-017-0832-7]
[19]
Aher A, Kok M, Sharma A, et al. CLASP suppresses microtubule catastrophes through a single TOG domain. Dev Cell 2018; 46(1): 40-58.
[http://dx.doi.org/10.1016/j.devcel.2018.05.032]
[20]
Kamada T, Kurokawa M, Kato T, et al. Proteomic analysis of bone marrow-adherent cells in rheumatoid arthritis and osteoarthritis. Int J Rheum Dis 2012; 15(2): 169-78.
[http://dx.doi.org/10.1111/j.1756-185X.2012.01702.x]
[21]
Xu W, Yang X, Li D, et al. Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: A comparative proteomic study. J Proteomics 2015; 113: 57-72.
[http://dx.doi.org/10.1016/j.jprot.2014.09.014]
[22]
Song L, You W, Wang P, Li F, Liu H. Transcriptomic analysis of the association between diabetes mellitus and myocardial infarction. Exp Clin Endocrinol Diabetes 2019; 127(9): 603-14.
[http://dx.doi.org/10.1055/a-0619-4412] [PMID: 29890546]
[23]
Kanter J, Bornfeldt KE, TEM M. Inflammation and diabetes-accelerated atherosclerosis: Myeloid cell mediators. Trends Endocrinol Metab 2013; 124(3): 137-44.
[http://dx.doi.org/10.1016/j.tem.2012.10.002]